Intuitive announced that the U.S. Food and Drug Administration (FDA) has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA (internal mammary artery) mobilization for cardiac revascularization.
“Opening the chest to perform surgical procedures can involve significant pain, high risk of complications, and long recovery times that can affect patients’ physical and psychological wellbeing,” said Intuitive chief executive officer Dave Rosa. “This clearance reflects our commitment to advancing minimally invasive cardiac surgery so more surgeons and care teams can pursue improved outcomes for their patients.”

"Thomas Fogarty, inventor of the embolectomy catheter which revolutionised blood clot surgery moves on to the next dimension.
While working as a scrub technician at Good Samaritan Hospital, he saw many patients die of blood clots and complications during blood clot surgery, which originally involved making large incisions in an artery and removing the clot with forceps. Nearly half of patients treated this way died or lost limbs."

THINK Surgical, Inc. and Zimmer Biomet Holdings, Inc.announced a multi-year extension of its Limited Exclusive Distribution and Supply Agreement following a successful partnership during the initial term of the agreement.
‍
The TMINI Robot is a state-of-the-art miniature, handheld, wireless robotic system designed to enable accurate and precise implant placement. It easily integrates into the OR with overhead active tracking, allowing for unrestricted patient access. The CT-based 3D surgical planning and the TMINI PRO^TM Workflow enable intraoperative adjustments to help fine-tune implant positioning and stability. The TMINI System is an open implant robotic system to empower surgeon implant choice."